Hypothalamic Dopamine Neurons is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Hypothalamic dopamine neurons are primarily located in the arcuate nucleus (ARC) and periventricular nucleus of the hypothalamus. These neurons play crucial roles in neuroendocrine regulation and have important connections to both the pituitary gland and other brain regions[1].
The hypothalamus contains several distinct dopaminergic populations:
| Taxonomy | ID | Name / Label |
|---|---|---|
| Cell Ontology (CL) | CL:4023026 | direct pathway medium spiny neuron |
The arcuate nucleus (also called the infundibular nucleus) is located:
Hypothalamic dopamine neurons project to[2]:
The primary function of hypothalamic dopamine neurons is to inhibit prolactin secretion from the anterior pituitary[3]. This pathway:
Dopamine interacts with growth hormone (GH) regulation through:
Hypothalamic dopamine influences reproduction through:
These neurons integrate metabolic signals:
Hypothalamic dopamine dysfunction is increasingly recognized in Parkinson's disease[4]:
Hypothalamic dopamine declines with normal aging:
Understanding hypothalamic dopamine has led to several therapeutic approaches:
Hypothalamic dopamine neurons synthesize dopamine through the canonical catecholamine pathway:
TIDA neurons have unique molecular features:
Although hypothalamic dopamine neurons are less affected than substantia nigra pars compacta neurons in PD, alpha-synuclein pathology can still impact these cells:
PD-related changes in hypothalamic dopamine:
Hypothalamic dopamine neurons integrate metabolic signals:
The study of Hypothalamic Dopamine Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Björklund A, Dunnett SB. Dopamine neuron systems in the brain: an update. 2007. ↩︎
Moore KE. The interactions between prolactin and dopaminergic neurons. 1987. ↩︎
Ben-Jonathan N, Hnasko R. Dopamine as a prolactin (PRL) inhibitor. 2001. ↩︎
Shulman LM, Minagar A, Weiner WJ. The peripheral and autonomic nervous system in Parkinson's disease. 2006. ↩︎
Kumer & Vrana, Tyrosine hydroxylase regulation (1996). 1996. ↩︎
Berry et al. AADC in neurotransmitter synthesis (2016). 2016. ↩︎
Ben-Jonathan & Hnasko, Dopamine and prolactin (2001). 2001. ↩︎
Jellinger, Lewy body distribution in hypothalamus (1999). 1999. ↩︎
Contin et al. Prolactin in PD (1994). 1994. ↩︎